Cancer Research Center, The First Affiliated Hospital, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China.
National Center for Liver Cancer, Second Military Medical University, Shanghai, 200438, China.
Sci China Life Sci. 2021 Aug;64(8):1281-1294. doi: 10.1007/s11427-020-1905-7. Epub 2021 Apr 9.
Liver cancer is one of the most common causes of cancer-related death worldwide and mainly includes hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Extracellular vesicles (EVs) are membrane-derived nanometer-sized vesicles that can be released by different cell types under normal and pathological conditions and thus play important roles in the transmission of biological information between cells. Increasing evidence suggests that liver cancer cell-derived EVs may help establish a favorable microenvironment to support the proliferation, invasion and metastasis of cancer cells. In this review, we summarized the role of EVs in the tumor microenvironment (TME) during the development and progression of liver cancer. As messenger carriers, EVs are loaded by various biomolecules, such as proteins, RNA, DNA, lipids and metabolites, making them potential liquid biopsy biomarkers for the diagnosis and prognosis of liver cancer. We also highlighted the progress of EVs as antigen carriers and EV-based therapeutics in preclinical studies of liver cancer.
肝癌是全球癌症相关死亡的主要原因之一,主要包括肝细胞癌 (HCC) 和胆管细胞癌 (CCA)。细胞外囊泡 (EVs) 是源自膜的纳米级囊泡,在正常和病理条件下可由不同类型的细胞释放,因此在细胞间传递生物信息方面发挥着重要作用。越来越多的证据表明,肝癌细胞衍生的 EVs 可能有助于建立有利于支持癌细胞增殖、侵袭和转移的微环境。在这篇综述中,我们总结了 EVs 在肝癌发展和进展过程中肿瘤微环境 (TME) 中的作用。作为信使载体,EVs 被各种生物分子(如蛋白质、RNA、DNA、脂质和代谢物)装载,使其成为肝癌诊断和预后的潜在液体活检生物标志物。我们还强调了 EVs 作为抗原载体和基于 EV 的治疗在肝癌临床前研究中的进展。